Stock listing

Dr. Reddy's Laboratories Ltd.

Selected listing: R1DY34 · BMFBOVESPA · BRL · BR

Dr. Reddy's Laboratories Ltd. (B3:R1DY34), Health Technology. Latest release Oct 7, 2026: Dr. Reddy's Laboratories Limited has informed the Exchange regarding…

R1DY34:BMFBOVESPABRLBRUpdated October 2, 2026

Ticker: B3:R1DY34
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: B3
Currency: BRL

Latest news from Dr. Reddy's Laboratories Ltd.

Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated October 07, 2026, titled "Intimation of Earnings call".

October 7, 2026

Dr. Reddy’s Announces the First-to-Market Launch of Sugammadex Injection 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials, a Generic Equivalent of Bridion®, in the United States

August 4, 2026

Dr. Reddy's Laboratories Ltd. Press Release Aug 01 2026

August 1, 2026

Dr. Reddy's Laboratories Ltd. Press Release Jul 23 2026

July 22, 2026

Dr. Reddy's Laboratories Ltd. Press Release Jul 13 2026

July 13, 2026

All Dr. Reddy's Laboratories Ltd. news →

Events

Replays

Dr. Reddy's Laboratories Ltd (RDY) Q1 2027 Earnings Call
Wed, Jul 22, 2026 · 10:00 AM ET
Watch
Dr. Reddy's Laboratories Ltd (RDY) Q4 2026 Earnings Call
Tue, May 12, 2026 · 10:00 AM ET
Watch
Dr. Reddy's Laboratories Ltd (RDY) Q3 2026 Earnings Call
Wed, Jan 21, 2026 · 07:30 PM ET
Watch

Research Dr. Reddy's Laboratories Ltd.

Dr. Reddy's Laboratories Ltd. company profile

View the public company page for Dr. Reddy's Laboratories Ltd. on 6ix.

Dr. Reddy's Laboratories Ltd. news

Read company news and market updates connected to Dr. Reddy's Laboratories Ltd..

Dr. Reddy's Laboratories Ltd. investor events

Find investor webinars, events, and replay context for Dr. Reddy's Laboratories Ltd..